188 related articles for article (PubMed ID: 23299085)
1. Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing for efficient antitumor activity.
Martín-Banderas L; Sáez-Fernández E; Holgado MÁ; Durán-Lobato MM; Prados JC; Melguizo C; Arias JL
Int J Pharm; 2013 Feb; 443(1-2):103-9. PubMed ID: 23299085
[TBL] [Abstract][Full Text] [Related]
2. BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs.
Chitkara D; Kumar N
Pharm Res; 2013 Sep; 30(9):2396-409. PubMed ID: 23756758
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs) using central composite design.
Yalcin TE; Ilbasmis-Tamer S; Takka S
Int J Pharm; 2018 Sep; 548(1):255-262. PubMed ID: 29969712
[TBL] [Abstract][Full Text] [Related]
4. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.
Intra J; Salem AK
J Drug Target; 2011 Jul; 19(6):393-408. PubMed ID: 20681752
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a stability indicating isocratic HPLC method for gemcitabine with application to drug release from poly lactic-co-glycolic acid nanoparticles and enzymatic degradation studies.
Chen G; Svirskis D; Wen J
J Pharm Pharmacol; 2015 Nov; 67(11):1528-36. PubMed ID: 26369422
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy.
Jaidev LR; Krishnan UM; Sethuraman S
Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():40-7. PubMed ID: 25492170
[TBL] [Abstract][Full Text] [Related]
7. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.
Esim O; Ozkan CK; Sarper M; Savaser A; Ozkan Y
Curr Drug Deliv; 2020; 17(7):622-628. PubMed ID: 32394837
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and mechanistic-insight into the anti-proliferative potential of PLGA-gemcitabine conjugate.
Khare V; Kour S; Alam N; Dubey RD; Saneja A; Koul M; Gupta AP; Singh D; Singh SK; Saxena AK; Gupta PN
Int J Pharm; 2014 Aug; 470(1-2):51-62. PubMed ID: 24810239
[TBL] [Abstract][Full Text] [Related]
10. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
Li X; Xu Y; Chen G; Wei P; Ping Q
Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine hydrochloride-loaded liposomes and nanoparticles: comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity.
Yalcin TE; Ilbasmis-Tamer S; Ibisoglu B; Özdemir A; Ark M; Takka S
Pharm Dev Technol; 2018 Jan; 23(1):76-86. PubMed ID: 28724327
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of gemcitabine and simvastatin through PLGA polymeric nanoparticles for the treatment of pancreatic cancer: in-vitro characterization, cellular uptake, and pharmacokinetic studies.
Jamil A; Aamir Mirza M; Anwer MK; Thakur PS; Alshahrani SM; Alshetaili AS; Telegaonkar S; Panda AK; Iqbal Z
Drug Dev Ind Pharm; 2019 May; 45(5):745-753. PubMed ID: 30632800
[TBL] [Abstract][Full Text] [Related]
13. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
Joshi G; Kumar A; Sawant K
Eur J Pharm Sci; 2014 Aug; 60():80-9. PubMed ID: 24810394
[TBL] [Abstract][Full Text] [Related]
14. Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival.
Allison Logan S; Brissenden AJ; Szewczuk MR; Neufeld RJ
Drug Des Devel Ther; 2017; 11():2239-2250. PubMed ID: 28814832
[TBL] [Abstract][Full Text] [Related]
15. Insulin-loaded PLGA microparticles: flow focusing versus double emulsion/solvent evaporation.
Cózar-Bernal MJ; Holgado MA; Arias JL; Muñoz-Rubio I; Martín-Banderas L; Alvarez-Fuentes J; Fernández-Arévalo M
J Microencapsul; 2011; 28(5):430-41. PubMed ID: 21736527
[TBL] [Abstract][Full Text] [Related]
16. Formulation and Pharmacokinetics of HSA-core and PLGA-shell Nanoparticles for Delivering Gemcitabine.
Wang X; Liang Y; Fei S; He H; Zhang Y; Yin T; Tang X
AAPS PharmSciTech; 2018 Feb; 19(2):812-819. PubMed ID: 29019099
[TBL] [Abstract][Full Text] [Related]
17. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
[TBL] [Abstract][Full Text] [Related]
19. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
McCarron PA; Donnelly RF; Marouf W
J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
